NOV 03, 2018 1:54 PM PDT

Potential new Tuberculosis Treatment Found in Dirt

WRITTEN BY: Carmen Leitch

A bacterium called Mycobacterium tuberculosis causes the disease tuberculosis (TB), which is treated with antibiotics. The pathogen is able to mutate, however, and evade therapeutics like rifamycin. Resistance to rifamycin or Rif has been steadily increasing, making it much harder to help TB patients get well. New research reported in Nature Communications may have found a solution to the resistance problem, however. Scientists discovered an antibiotic in dirt, which can destroy the pathogenic microbe.

Soil is a rich source of bacteria, some of which produce molecules that act as natural antibiotics. / Credit: Jacob Arthur Pritchard for The Rockefeller University

The drug that has been used to treat TB, Rif, targets a bacterial enzyme called RNA polymerase (RNAP). If the RNAP mutates, however, the drug often stops working. Researchers decided to search for a new antibiotic that acted similarly to Rif, but kept working even after mutations occurred in the RNAP. 

"Rifamycin is naturally produced by a bacterium," said Sean F. Brady, the Evnin Professor. "So I wanted to find out whether nature had also made Rif analogs - molecules that look like rifamycin, but that have slight differences."

In soil, bacteria have to compete with one another. They might create toxins to gain an edge in that competition. Rif is one such bacterial toxin. The researchers combed through the soil using genomic tools that could identify microbes with genes that would indicate the presence of a molecule with similarities to Rif. They were able to find natural antibiotics called kanglemycins, or kangs; they have genes in common with rifamycin. They also looked to be capable of targeting bacteria that Rif cannot.

Because the tuberculosis bacterium was able to evolve so it could evade Rif, it’s possible a similar thing happened in soil. That may have led to the creation of kangs, in turn.

"It's possible that natural antibiotics are under the same selective pressure that we're putting antibiotics under in the clinic," explained Brady. "And if that's the case, then we would see natural analogs to rifamycin, like kangs, that overcome resistance."

Scientists Elizabeth Campbell, a research associate professor, Seth A. Darst, the Jack Fishman Professor, and senior research associate Mirjana Lilic wanted to know whether the newly found antibiotics had any efficacy against tuberculosis. They began by analyzing their structure, and found that while kangs resemble rifamycin, there are unique features to these antibiotics.  The addition of a sugar and an acid to the core structure of the molecule give it a new way to attach to RNAP. That enables the kangs to disrupt bacteria that aren’t affected by Rif.

"We found that the extra sugar allows the kanglemycin to dock into a pocket of RNAP that other drugs didn't take advantage of," explained Campbell. Before this study, she said, scientists did not know that such a pocket even existed. Its discovery has opened up a new target in drug design.

"We'd still like to see increased potency and broader activity against resistant bugs," added Campbell. "But this study tells us that we're on the right track."


Sources: AAAS/Eurekalert! Via Rockefeller University, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 07, 2020
Microbiology
JAN 07, 2020
The Unusual Microbiomes of Bats and Birds
Humans might have a critical dependence on the microbes in their guts, but it seems that not all animals do....
FEB 10, 2020
Microbiology
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries....
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Should You Really be Scared of the Coronavirus?
As of February 21st, the death toll for coronavirus reached 2,250, 55,707 currently infected, of which 12,066 (22%) are in a serious or critical condition....
FEB 28, 2020
Cannabis Sciences
FEB 28, 2020
Vaping Harms Microbiome, Increases Infection and Inflammation
Researchers have found that vaping e-cigarettes may change the composition of the mouth’s microbiome, something that leads to higher risks of inflamm...
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, has been approved as a procedure t...
MAR 10, 2020
Microbiology
MAR 10, 2020
Study Suggests 14-Day Quarantine for SARS-CoV-2 is Reasonable
The vast majority (97.5%) of people will develop symptoms of infection within 11.5 days of exposure to the virus....
Loading Comments...